[STOK] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -67.54%
YoY- -32.02%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 4,216 2,802 3,308 -2,481 5,152 3,269 2,905 28.15%
PBT -26,374 -26,958 -24,542 -30,654 -22,545 -25,655 -26,111 0.66%
Tax 1,070 10,714 -3,288 -3,178 -4,248 -3,608 -2,032 -
NP -26,374 -26,958 -24,542 -30,654 -18,297 -22,047 -24,079 6.25%
Tax Rate - - - - - - - -
Total Cost 30,590 29,760 27,850 28,173 23,449 25,316 26,984 8.71%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -625.57 -962.10 -741.90 1,235.55 -355.14 -674.43 -828.88 -17.09%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.57 -0.60 -0.55 -0.69 -0.43 -0.56 -0.61 -4.41%
EPS Diluted -0.57 -0.60 -0.55 -0.69 -0.43 -0.56 -0.61 -4.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.